Octagon Therapeutics

Octagon Therapeutics is a preclinical-stage biopharmaceutical company developing antibiotics for multidrug-resistant infections. Octagon has demonstrated efficacy against the most critical pathogens identified by the World Health Organization. Octagon's headquarters is located at the Pagliuca Life Lab, adjacent to the Harvard campus. This state-of-the-art facility enables Octagon to accelerate the development of our vital drugs with minimal administrative costs and equipment expenses. Octagon's management team comprises highly skilled scientists, clinicians, and entrepreneurs with decades of research experience and deep expertise in drug development. The scientific team is growing and continuously adding top-tier research talent.